Blog

16 December 2013 - The IQWiG has completed its reassessment of vemurafenib (Zelboraf), a drug used to treat adults with a  certain type ...

The fixed combination of the drugs tafluprost and timolol (trade name: Taptiqom) has been approved in Germany since December 2014 ...

Vedolizumab (trade name Entyvio) has been approved since May 2014 for the treatment of patients suffering from moderate to severe form ...

The immunosuppressant fingolimod hydrochloride (trade name Gilenya) was approved in May 2014 for a new indication; adults with highly active and ...

[:content [\C \a \p \r \e \l \s \a \space \( \v \a \n \d \e \t \a \n \i \b \) \space \h \a \s \space \b \e \e \n \space \a \p \p \r \o \v \e \d \space \i \n \space \G \e \r \m \a \n \y \space \s \i \n \c \e \space \F \e \b \r \u \a \r \y \space \2 \0 \1 \2 \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \a \d \u \l \t \space \p \a \t \i \e \n \t \s \space \w \h \o \space \h \a \v \e \space \a \space \p \a \r \t \i \c \u \l \a \r " ..."]]

17 Novermber 2014 - The fixed combination of canagliflozin with metformin (trade name: Vokanamet) has been approved since April 2014 ...

Sipuleucel-T (trade name Provenge) has been approved since September 2014 for men with metastatic prostate cancer who have few or ...

Albiglutide (trade name Eperzan) was approved in March 2014 for use by adults with type 2 diabetes mellitus where diet and exercise do ...

The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis ...

Sipuleucel-T (Provenge) has been authorised since September 2014 for use by men with metastatic prostate cancer who have little or no ...

[:content [\V \i \s \m \o \d \e \g \i \b \space \( \E \r \i \v \e \d \g \e \) \space \i \s \space \a \p \p \r \o \v \e \d \space \f \o \r \space \t \h \e \space \t \r \e \a \t \m \e \n \t \space \o \f \space \p \a \t \i \e \n \t \s \space \w \i \t \h \space \t \w \o \space \f \o \r \m \s \space \o \f \space \b \a \s \a \l \space \c \e \l \l \space \c \a \r \c \i \n \o \m \a \: \space \o \n \e \space \w \i \t \h \space \s \y \m \p \t \o \m \a \t \i \c \space \m \e \t \a \s \t \a \t \i \c " ..."]]

[:content [\1 \4 \space \D \e \c \e \m \b \e \r \space \2 \0 \1 \3 \space \- \space \B \M \S \space \& \space \A \s \t \r \a \Z \e \n \e \c \a \space \h \a \v \e \  \p \u \l \l \e \d \space \t \h \e \i \r \space \d \i \a \b \e \t \e \s \space \t \r \e \a \t \m \e \n \t \space \F \o \r \x \i \g \a \space \( \d \a \p \a \g \l \i \f \l \o \z \i \n \) \space \f \r \o \m \space \t \h \e \space \G \e \r \m \a \n \space \m \a \r \k \e \t \space \a \f \t \e \r \space \t \h \e \space \c \o \m \p \a \n \i \e \s " ..."]]

[:content [\3 \1 \space \M \a \r \c \h \space \2 \0 \1 \4 \space \- \  " ..."]]

Ruxolitinib (trade name: Jakavi) has been approved since August 2012 for the treatment of adults with myelofibrosis. In an early ...